Patients were randomized to receive one of three antiemetic regimens: a single 8- mg i.v. ondansetron dose, a single 32-mg i.v. ondansetron dose, or an 8-mg i.v. ondansetron loading dose followed ...

Purpose: The antiemetic effectiveness of ondansetron 8 mg i.v., ondansetron 32 mg i.v., and granisetron 10 µg/kg or 1 mg i.v. as prophylaxis in breast cancer patients receiving cyclophosphamide ...